Subsequent to the end of the third quarter of 2024, the Company closed its previously announced registered direct offering ... of Valley Veterinary animal hospital in the fourth quarter of 2023.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Furthermore, it is noted that Innocan has made strong progress with the FDA's Center for Veterinary Medicine (CVM) with the issuance of an Investigational New Animal Drug (INAD) designation in July.

Move comes as a campaign group warns that plans for the latest round of culling activity mean it is likely badgers will ...

A professional accused of performing operations that were outside his competence levels has pledged he will never seek to ...

Zoetis has announced a further delay in the supply of Equip Artervac in the UK, due to a manufacturing issue. The company now expects the vaccine will not be available until June 2025. The company ...

Class A ( (IVP)) has issued an announcement. Inspire Veterinary Partners, Inc. has announced a $2.5 million registered direct offering of Class A common stock at $0.25 per share, with Spartan ...

VIRGINIA BEACH, VA / ACCESSWIRE / October 22, 2024 / Inspire Veterinary Partners ... shares of Class A common stock in a registered direct offering, at a price per share of $0.25.

Inspire Veterinary (IVP) Partners has entered into ... 10,000,000 million shares of Class A common stock in a registered direct offering, at a price per share of $0.25. The offering is expected ...